Izumi A, Minakami H, Matsubara S, Sato I
Department of Obstetrics and Gynecology, Jichi Medical School, Tochigi, Japan.
J Obstet Gynaecol Res. 1998 Aug;24(4):275-9. doi: 10.1111/j.1447-0756.1998.tb00089.x.
We prospectively evaluated the antenatal changes in antithrombin-III (AT-III) activity and liver enzymes in a woman with a triplet pregnancy. A gradual decline in AT-III activity occurred in the absence of clinical signs of preeclampsia and preceded the onset of the typical HELLP syndrome in this patient. Monitoring of AT-III activity might help to avoid the development of severe HELLP syndrome.
我们前瞻性地评估了一名三胎妊娠女性的抗凝血酶III（AT-III）活性和肝酶的产前变化。在该患者中，抗凝血酶III活性逐渐下降，且无先兆子痫的临床体征，并先于典型的HELLP综合征出现。监测抗凝血酶III活性可能有助于避免严重HELLP综合征的发生。
